ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 185 filers reported holding ACORDA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,035,000 | -30.9% | 52,987 | +1.6% | 0.56% | -25.7% |
| Q2 2018 | $1,497,000 | +16.7% | 52,163 | -3.8% | 0.76% | +10.0% |
| Q1 2018 | $1,283,000 | +26.4% | 54,230 | +14.6% | 0.69% | +21.5% |
| Q4 2017 | $1,015,000 | -27.8% | 47,313 | -14.7% | 0.57% | -29.7% |
| Q3 2017 | $1,406,000 | +28.4% | 55,435 | 0.0% | 0.81% | +23.2% |
| Q2 2017 | $1,095,000 | +16.6% | 55,435 | +8.7% | 0.66% | +14.9% |
| Q1 2017 | $939,000 | -3.3% | 51,013 | 0.0% | 0.57% | -10.2% |
| Q4 2016 | $971,000 | -13.6% | 51,013 | -4.7% | 0.64% | -21.6% |
| Q3 2016 | $1,124,000 | – | 53,508 | – | 0.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 815,838 | $27,192,000 | 3.30% |
| ARMISTICE CAPITAL, LLC | 186,000 | $6,199,000 | 2.23% |
| 1492 Capital Management LLC | 95,639 | $3,188,000 | 2.02% |
| Partner Investment Management, L.P. | 19,498 | $650,000 | 0.91% |
| Tekla Capital Management LLC | 680,862 | $22,693,000 | 0.82% |
| PFM Health Sciences, LP | 817,396 | $27,244,000 | 0.69% |
| HighPoint Advisor Group LLC | 11,829 | $394,000 | 0.61% |
| ARBOR CAPITAL MANAGEMENT LLC | 89,183 | $2,972,000 | 0.56% |
| Pergamon Offshore Advisors, L.P. | 15,950 | $532,000 | 0.56% |
| Penn Capital Management Company, LLC | 390,212 | $13,006,000 | 0.54% |